BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1987497)

  • 1. DNA flow cytometry in the prognosis of primary malignant melanoma.
    Bartkowiak D; Schumann J; Otto FJ; Lippold A; Drepper H
    Oncology; 1991; 48(1):39-43. PubMed ID: 1987497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential DNA flow cytometry in metastatic malignant melanoma.
    Bartkowiak D; Otto F; Schumann J; Lippold A; Drepper H
    Oncology; 1991; 48(2):154-7. PubMed ID: 1997939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA index and S phase fraction in uveal malignant melanomas.
    Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
    Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
    Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
    Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of aneuploidy in melanoma of the extremity.
    van Oven MW; Baas PC; Oosterhuis JW; Schraffordt Koops H; Dam-Meiring A
    Cancer; 1992 Jul; 70(1):109-13. PubMed ID: 1606531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Significance of monoclonal and multiclonal varieties of DNA aneuploidy.
    Campanella R; Russo A; Plaja S; Bazan V; Pavone C; Corselli G; Pavone-Macaluso M
    Eur Urol; 1992; 21(1):58-63. PubMed ID: 1606985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of flow cytometry and the cell proliferation index in choroidal melanoma].
    Ranty ML; Quintyn JC; Courville P; Brasseur G
    J Fr Ophtalmol; 2003 Sep; 26(7):725-9. PubMed ID: 13130261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications.
    el-Naggar AK; Ordóñez NG; Sara A; McLemore D; Batsakis JG
    Cancer; 1991 Apr; 67(8):2173-9. PubMed ID: 2004337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
    Talve LA; Collan YU; Ekfors TO
    Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
    Klapperstück T; Wohlrab W
    Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Prognostic implications.
    Salvati F; Teodori L; Gagliardi L; Signora M; Aquilini M; Storniello G
    Chest; 1989 Nov; 96(5):1092-8. PubMed ID: 2553342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
    Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
    Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.